• Tuesday,October 08,2024
ururembotoursandtravel.com
X

Cancer Epi & Genetics on X: The end of 2023 is a time to reflect

$ 26.50

4.8 (601) In stock

Share

Cancers January-1 2023 - Browse Articles

Meta-analysis of expression and the targeting of cell adhesion associated genes in nine cancer types – A one research lab re-evaluation - Computational and Structural Biotechnology Journal

Heterogeneity and transcriptional drivers of triple-negative breast cancer - ScienceDirect

Stage 4 Asbestos-Related Lung Cancer

Whole genome and exome sequencing reference datasets from a multi-center and cross-platform benchmark study

Stage 4 Lung Cancer Life Expectancy

Frontiers Navigating the genetic landscape of breast cancer in South Africa amidst a developing healthcare system

Cancers August-1 2023 - Browse Articles

Research into targeted treatments, better prediction models in breast cancer funded

Frontiers Epigenetic liquid biopsies for minimal residual disease, what's around the corner?

Frontiers Degradome-focused RNA interference screens to identify proteases important for breast cancer cell growth